Cargando…
Celastrol alleviates renal fibrosis by upregulating cannabinoid receptor 2 expression
Renal fibrosis is the final manifestation of various chronic kidney diseases, and no effective therapy is available to prevent or reverse it. Celastrol, a triterpene that derived from traditional Chinese medicine, is a known potent anti-fibrotic agent. However, the underlying mechanisms of action of...
Autores principales: | Tang, Ming, Cao, Xu, Zhang, Kun, Li, You, Zheng, Quan-you, Li, Gui-qing, He, Qian-hui, Li, Shu-jing, Xu, Gui-lian, Zhang, Ke-qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964092/ https://www.ncbi.nlm.nih.gov/pubmed/29789558 http://dx.doi.org/10.1038/s41419-018-0666-y |
Ejemplares similares
-
Tumor necrosis factor superfamily 14 is critical for the development of renal fibrosis
por: Li, You, et al.
Publicado: (2020) -
Increased expression of Fibrinogen-Like Protein 2 is associated with poor prognosis in patients with clear cell renal cell carcinoma
por: Tang, Ming, et al.
Publicado: (2017) -
Complement component 3 deficiency prolongs MHC-II disparate skin allograft survival by increasing the CD4(+) CD25(+) regulatory T cells population
por: Zheng, Quan-you, et al.
Publicado: (2016) -
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2
por: Yang, Longhe, et al.
Publicado: (2014) -
LIGHT deficiency attenuates acute kidney disease development in an in vivo experimental renal ischemia and reperfusion injury model
por: Zheng, Quan-you, et al.
Publicado: (2022)